Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes

Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes

US Patent 5583121 · Granted Dec 10, 1996

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Crystalline forms of a lysyl oxidase-like 2 inhibitor and methods of making2022
Crystalline forms of a lysyl oxidase-like 2 inhibitor and methods of making2020
DP2 antagonist and uses thereof2017
Methods and compositions for treating trauma-hemorrhage using estrogen and deriv2016
Methods and compositions for treating trauma-hemorrhage using estrogen and deriv2016
DP2 antagonist and uses thereof2014
Triamine derivative melanocortin receptor ligands and methods of using same2004
Melanocortin receptor-3 ligands to treat sexual dysfunction2003
Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock2000
Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock2000
Process for preparing synthetic matrix metalloprotease inhibitors1999
Oligosaccharide glycosides having mammalian immunosuppresive and tolerogenic pro1999